Changes in Aβ biomarkers and associations with APOE genotype in 2 longitudinal cohorts

Susan M. Resnick, Murat Bilgel, Abhay R Moghekar, Yang An, Qing Cai, Mei Cheng Wang, Madhav Thambisetty, Jerry Ladd Prince, Yun Zhou, Anja Soldan, Dean Foster Wong, Richard J. O'Brien, Luigi Ferrucci, Marilyn Albert

Research output: Contribution to journalArticle

Abstract

Apolipoprotein E (APOE) genotype influences onset age of Alzheimer's disease but effects on disease progression are less clear. We investigated amyloid-β (Aβ) levels and change in relationship to APOE genotype, using 2 different measures of Aβ in 2 different longitudinal cohorts. Aβ accumulation was measured using positron emission tomography (PET) imaging and 11C-Pittsburgh compound-B (PiB) in 113 Baltimore Longitudinal Study of Aging participants (mean age 77.3 years; 107 normal, 6 cognitively impaired) and cerebral spinal fluid (CSF) Aβ1 -42 assays in 207 BIOCARD study participants (mean age 62 years; 195 normal, 12 cognitively impaired). Participants in both cohorts had up to 7 serial assessments (mean 2.3-2.4). PET-PiB retention increased and CSF Aβ1-42 declined longitudinally. APOE ε4 was significantly associated with higher PET-PiB retention and lower CSF Aβ1-42, independent of age and sex, but APOE genotype did not significantly affect Aβ change over time. APOE ε4 carriers may be further along in the disease process, consistent with earlier brain Aβ deposition and providing a biological basis for APOE genotype effects on onset age of Alzheimer's disease.

Original languageEnglish (US)
Pages (from-to)2333-2339
Number of pages7
JournalNeurobiology of Aging
Volume36
Issue number8
DOIs
StatePublished - 2015

Fingerprint

Apolipoproteins E
Biomarkers
Genotype
Positron-Emission Tomography
Apolipoprotein E4
Age of Onset
Alzheimer Disease
Baltimore
Amyloid
Longitudinal Studies
Disease Progression
Brain
2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole

Keywords

  • Apolipoprotein E genotype
  • Biomarkers
  • CSF Aβ
  • Longitudinal
  • PET amyloid imaging

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)
  • Aging
  • Developmental Biology
  • Geriatrics and Gerontology

Cite this

Changes in Aβ biomarkers and associations with APOE genotype in 2 longitudinal cohorts. / Resnick, Susan M.; Bilgel, Murat; Moghekar, Abhay R; An, Yang; Cai, Qing; Wang, Mei Cheng; Thambisetty, Madhav; Prince, Jerry Ladd; Zhou, Yun; Soldan, Anja; Wong, Dean Foster; O'Brien, Richard J.; Ferrucci, Luigi; Albert, Marilyn.

In: Neurobiology of Aging, Vol. 36, No. 8, 2015, p. 2333-2339.

Research output: Contribution to journalArticle

Resnick, Susan M. ; Bilgel, Murat ; Moghekar, Abhay R ; An, Yang ; Cai, Qing ; Wang, Mei Cheng ; Thambisetty, Madhav ; Prince, Jerry Ladd ; Zhou, Yun ; Soldan, Anja ; Wong, Dean Foster ; O'Brien, Richard J. ; Ferrucci, Luigi ; Albert, Marilyn. / Changes in Aβ biomarkers and associations with APOE genotype in 2 longitudinal cohorts. In: Neurobiology of Aging. 2015 ; Vol. 36, No. 8. pp. 2333-2339.
@article{58206343699e4b71a48030adc9b7b1ed,
title = "Changes in Aβ biomarkers and associations with APOE genotype in 2 longitudinal cohorts",
abstract = "Apolipoprotein E (APOE) genotype influences onset age of Alzheimer's disease but effects on disease progression are less clear. We investigated amyloid-β (Aβ) levels and change in relationship to APOE genotype, using 2 different measures of Aβ in 2 different longitudinal cohorts. Aβ accumulation was measured using positron emission tomography (PET) imaging and 11C-Pittsburgh compound-B (PiB) in 113 Baltimore Longitudinal Study of Aging participants (mean age 77.3 years; 107 normal, 6 cognitively impaired) and cerebral spinal fluid (CSF) Aβ1 -42 assays in 207 BIOCARD study participants (mean age 62 years; 195 normal, 12 cognitively impaired). Participants in both cohorts had up to 7 serial assessments (mean 2.3-2.4). PET-PiB retention increased and CSF Aβ1-42 declined longitudinally. APOE ε4 was significantly associated with higher PET-PiB retention and lower CSF Aβ1-42, independent of age and sex, but APOE genotype did not significantly affect Aβ change over time. APOE ε4 carriers may be further along in the disease process, consistent with earlier brain Aβ deposition and providing a biological basis for APOE genotype effects on onset age of Alzheimer's disease.",
keywords = "Apolipoprotein E genotype, Biomarkers, CSF Aβ, Longitudinal, PET amyloid imaging",
author = "Resnick, {Susan M.} and Murat Bilgel and Moghekar, {Abhay R} and Yang An and Qing Cai and Wang, {Mei Cheng} and Madhav Thambisetty and Prince, {Jerry Ladd} and Yun Zhou and Anja Soldan and Wong, {Dean Foster} and O'Brien, {Richard J.} and Luigi Ferrucci and Marilyn Albert",
year = "2015",
doi = "10.1016/j.neurobiolaging.2015.04.001",
language = "English (US)",
volume = "36",
pages = "2333--2339",
journal = "Neurobiology of Aging",
issn = "0197-4580",
publisher = "Elsevier Inc.",
number = "8",

}

TY - JOUR

T1 - Changes in Aβ biomarkers and associations with APOE genotype in 2 longitudinal cohorts

AU - Resnick, Susan M.

AU - Bilgel, Murat

AU - Moghekar, Abhay R

AU - An, Yang

AU - Cai, Qing

AU - Wang, Mei Cheng

AU - Thambisetty, Madhav

AU - Prince, Jerry Ladd

AU - Zhou, Yun

AU - Soldan, Anja

AU - Wong, Dean Foster

AU - O'Brien, Richard J.

AU - Ferrucci, Luigi

AU - Albert, Marilyn

PY - 2015

Y1 - 2015

N2 - Apolipoprotein E (APOE) genotype influences onset age of Alzheimer's disease but effects on disease progression are less clear. We investigated amyloid-β (Aβ) levels and change in relationship to APOE genotype, using 2 different measures of Aβ in 2 different longitudinal cohorts. Aβ accumulation was measured using positron emission tomography (PET) imaging and 11C-Pittsburgh compound-B (PiB) in 113 Baltimore Longitudinal Study of Aging participants (mean age 77.3 years; 107 normal, 6 cognitively impaired) and cerebral spinal fluid (CSF) Aβ1 -42 assays in 207 BIOCARD study participants (mean age 62 years; 195 normal, 12 cognitively impaired). Participants in both cohorts had up to 7 serial assessments (mean 2.3-2.4). PET-PiB retention increased and CSF Aβ1-42 declined longitudinally. APOE ε4 was significantly associated with higher PET-PiB retention and lower CSF Aβ1-42, independent of age and sex, but APOE genotype did not significantly affect Aβ change over time. APOE ε4 carriers may be further along in the disease process, consistent with earlier brain Aβ deposition and providing a biological basis for APOE genotype effects on onset age of Alzheimer's disease.

AB - Apolipoprotein E (APOE) genotype influences onset age of Alzheimer's disease but effects on disease progression are less clear. We investigated amyloid-β (Aβ) levels and change in relationship to APOE genotype, using 2 different measures of Aβ in 2 different longitudinal cohorts. Aβ accumulation was measured using positron emission tomography (PET) imaging and 11C-Pittsburgh compound-B (PiB) in 113 Baltimore Longitudinal Study of Aging participants (mean age 77.3 years; 107 normal, 6 cognitively impaired) and cerebral spinal fluid (CSF) Aβ1 -42 assays in 207 BIOCARD study participants (mean age 62 years; 195 normal, 12 cognitively impaired). Participants in both cohorts had up to 7 serial assessments (mean 2.3-2.4). PET-PiB retention increased and CSF Aβ1-42 declined longitudinally. APOE ε4 was significantly associated with higher PET-PiB retention and lower CSF Aβ1-42, independent of age and sex, but APOE genotype did not significantly affect Aβ change over time. APOE ε4 carriers may be further along in the disease process, consistent with earlier brain Aβ deposition and providing a biological basis for APOE genotype effects on onset age of Alzheimer's disease.

KW - Apolipoprotein E genotype

KW - Biomarkers

KW - CSF Aβ

KW - Longitudinal

KW - PET amyloid imaging

UR - http://www.scopus.com/inward/record.url?scp=84952638856&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84952638856&partnerID=8YFLogxK

U2 - 10.1016/j.neurobiolaging.2015.04.001

DO - 10.1016/j.neurobiolaging.2015.04.001

M3 - Article

C2 - 26004017

AN - SCOPUS:84952638856

VL - 36

SP - 2333

EP - 2339

JO - Neurobiology of Aging

JF - Neurobiology of Aging

SN - 0197-4580

IS - 8

ER -